Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:government_agency
|
| gptkbp:country |
gptkb:India
|
| gptkbp:establishedIn |
1961
|
| gptkbp:fullName |
gptkb:Drugs_Controller_General_of_India
|
| gptkbp:headquartersLocation |
gptkb:New_Delhi
|
| gptkbp:leader |
gptkb:Dr._Rajeev_Singh_Raghuvanshi
|
| gptkbp:numberOfIssues |
guidelines for pharmaceutical industry
|
| gptkbp:parentOrganization |
gptkb:Central_Drugs_Standard_Control_Organization
|
| gptkbp:regulates |
clinical trials in India
distribution of drugs in India import of drugs in India manufacture of drugs in India sale of drugs in India |
| gptkbp:reportsTo |
gptkb:Ministry_of_Health_and_Family_Welfare
|
| gptkbp:responsibleFor |
regulation of pharmaceutical and medical device products in India
approval of licenses of specified categories of drugs |
| gptkbp:website |
https://cdsco.gov.in
|
| gptkbp:bfsParent |
gptkb:ChAdOx1_nCoV-19_vaccine
gptkb:Drugs_Controller_General_of_India |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
DCGI
|